News and events
25.12.2007 TomoTherapy(R) Cancer Treatment Technology Debuts In Switzerland
TomoTherapy Incorporated (NASDAQ: TTPY) announced that the University Hospital of Lausanne (CHUV) has begun treating patients with the TomoTherapy(R) ... read more
24.12.2007 Gold Nanoparticle Probes May Allow Earlier Cancer Detection
Using tiny gold particles embedded with dyes, researchers have shown that they can identify tumors under the skin of a living animal. These tools may ... read more
23.12.2007 $5 Million NIH Grant For Lupus Research At UT Southwestern
The division of rheumatic diseases in the Department of Internal Medicine at UT Southwestern Medical Center has been awarded a five-year, $5 million g... read more
23.12.2007 Oncolytics Biotech Inc. Completes Patient Enrolment In U.K. Phase Ia/Ib Combination REOLYSINá¢/Radiation Clinical Trial
Oncolytics Biotech Inc. has completed patient enrolment in its Phase Ia/Ib U.K. clinical trial investigating the intratumoural delivery of REOLYSINá... read more
22.12.2007 Pain Killer Skin Patch Gets Second FDA Safety Warning
The Fentanyl transdermal system, a skin patch that provides powerful pain relief is the source of a second safety warning by the Food and Drug Adminis... read more
22.12.2007 Award For Influential Institute Professor Of Radiological Physics
Professor Steve Webb , Head of the Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust has this... read more
20.12.2007 Uninsured Americans Have Poorer Cancer Survival, Report
A new report by a major US cancer charity has found that uninsured Americans are less likely to survive cancer, less likely to be screened for it, and... read more
19.12.2007 Study Finds Outcomes Of High-Risk Cancer Operations In 80-Year-Olds Worse Than Reported
New research published in the December issue of The Journal of the American College of Surgeons shows that outcomes of high-risk cancer operations in ... read more
18.12.2007 New Nanotechnology Partnership Promises Hope For Cancer Sufferers
The California NanoSystems Institute (CNSI) at UCLA and NanoPacific Holdings Inc. have announced a partnership to commercialize a mechanized, nanopart... read more
18.12.2007 Amount Of HER-2 Gene Amplification As Assessed By FISH Is Linked To Magnitude Of Survival Benefit In Patients With Locally Advanced Breast Cancer
Patients with locally advanced breast cancers whose tumours contain high numbers of copies of the gene for the human epidermal growth factor receptor ... read more
Ñòðàíèöà 73 èç 100
< Previous 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100 Next >
Deceases & treatment
- Specific immunotherapy (xenovaccinotherapy) for cancer
- T-cell vaccination (autovaccinotherapy) for autoimmune diseases
- Regenarative therapy
- Clinical application of stem celltransplantation
- Cell transplantation (CT) in treating severe neurological disorders (general information)
- Hepatic diseases
- Osteomielitis
- Arthrosis
